The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer
Abstract
Purpose: To develop and validate a radiomics nomogram for preoperative prediction of lymph node (LN) metastasis in patients with colorectal cancer (CRC). Patients and Methods: The prediction model was developed in a primary cohort that consisted of 326 patients with clinicopathologically confirmed CRC, and data was gathered from January 2007 to April 2010. Radiomic features were extracted from portal venous–phase computed tomography (CT) of CRC. Lasso regression model was used for data dimension reduction, feature selection, and radiomics signature building. Multivariable logistic regression analysis was used to develop the predicting model, we incorporated the radiomics signature, CT-reported LN status, and independent clinicopathologic risk factors, and this was presented with a radiomics nomogram. The performance of the nomogram was assessed with respect to its calibration, discrimination, and clinical usefulness. Internal validation was assessed. An independent validation cohort contained 200 consecutive patients from May 2010 to December 2011. Results: The radiomics signature, which consisted of 24 selected features, was significantly associated with LN status (P < .001 for both primary and validation cohorts). Predictors contained in the individualized prediction nomogram included the radiomics signature, CT-reported LN status, and carcinoembryonic antigen level. Addition of histologic grade to the nomogram failed to show incremental prognostic value. The model showed good discrimination, with a C-index of 0.736 (C-index, 0.759 and 0.766 through internal validation), and good calibration. Application of the nomogram in the validation cohort still gave good discrimination (C-index, 0.778 [95% CI, 0.769 to 0.787]) and good calibration. Decision curve analysis demonstrated that the radiomics nomogram was clinically useful. Conclusion: This study presents a radiomics nomogram that incorporates the radiomics signature, CT-reported LN status, and clinical risk factors, which can be conveniently used to facilitate the preoperative individualized prediction of LN metastasis in patients with CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Harrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
Radiomics: Images Are More than Pictures, They Are Data
Gillies, R. J., Kinahan, P. E., & Hricak, H. (2016) · Radiology · doi:10.1148/radiol.2015151169 · Cited by 8,421
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Radiomics: extracting more information from medical images using advanced feature analysis
Lambin, P., Rios-Velazquez, E., Leijenaar, R., Carvalho, S., van Stiphout, R. G. P. M., Granton, P., Zegers, C. M. L., Gillies, R., Boellard, R., Dekker, A., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.11.036 · Cited by 6,084
Moons, K. G. M., Altman, D. G., Reitsma, J. B., Ioannidis, J. P. A., Macaskill, P., Steyerberg, E. W., Vickers, A. J., Ransohoff, D. F., & Collins, G. S. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0698 · Cited by 5,147
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
Aerts, H. J. W. L., Velazquez, E. R., Leijenaar, R. T. H., Parmar, C., Grossmann, P., Carvalho, S., Bussink, J., Monshouwer, R., Haibe-Kains, B., Rietveld, D., et al. (2014) · Nature Communications · doi:10.1038/ncomms5006 · Cited by 5,132
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · BMJ · doi:10.1136/bmj.g7594 · Cited by 4,388
Cited by
Radiomics: the bridge between medical imaging and personalized medicine
Lambin, P., Leijenaar, R. T. H., Deist, T. M., Peerlings, J., de Jong, E. E. C., van Timmeren, J., Sanduleanu, S., Larue, R. T. H. M., Even, A. J. G., Jochems, A., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.141 · Cited by 5,688
Kather, J. N., Krisam, J., Charoentong, P., Luedde, T., Herpel, E., Weis, C.-A., Gaiser, T., Marx, A., Valous, N. A., Ferber, D., et al. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002730 · Cited by 1,082
“Thesamplesizeof thiscohortwaschosensuchthat thepatientnumberwascomparableto thesamplesizesin similarstudies[35,36].”
Liu, Z., Wang, S., Dong, D., Wei, J., Fang, C., Zhou, X., Sun, K., Li, L., Li, B., Wang, M., et al. (2019) · Theranostics · doi:10.7150/thno.30309 · Cited by 967
Self-citationLimkin, E. J., Sun, R., Dercle, L., Zacharaki, E. I., Robert, C., Reuzé, S., Schernberg, A., Paragios, N., Deutsch, E., & Ferté, C. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx034 · Cited by 757
Xu, X., Zhang, H.-L., Liu, Q.-P., Sun, S.-W., Zhang, J., Zhu, F.-P., Yang, G., Yan, X., Zhang, Y.-D., & Liu, X.-S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.023 · Cited by 706
Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer
Zheng, X., Yao, Z., Huang, Y., Yu, Y., Wang, Y., Liu, Y., Mao, R., Li, F., Xiao, Y., Wang, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15027-z · Cited by 607
Self-citationLiu, Z., Zhang, X.-Y., Shi, Y.-J., Wang, L., Zhu, H.-T., Tang, Z., Wang, S., Li, X.-T., Tian, J., & Sun, Y.-S. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1038 · Cited by 547
Self-citationWang, K., Lu, X., Zhou, H., Gao, Y., Zheng, J., Tong, M., Wu, C., Liu, C., Huang, L., Jiang, T., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316204 · Cited by 500
Self-citationZhang, B., Tian, J., Dong, D., Gu, D., Dong, Y., Zhang, L., Lian, Z., Liu, J., Luo, X., Pei, S., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2910 · Cited by 494
Self-citationLiu, Z., Li, Z., Qu, J., Zhang, R., Zhou, X., Li, L., Sun, K., Tang, Z., Jiang, H., Li, H., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3190 · Cited by 491
Self-citationBeyond imaging: The promise of radiomics
Avanzo, M., Stancanello, J., & El Naqa, I. (2017) · Physica Medica · doi:10.1016/j.ejmp.2017.05.071 · Cited by 483
Wang, S., Shi, J., Ye, Z., Dong, D., Yu, D., Zhou, M., Liu, Y., Gevaert, O., Wang, K., Zhu, Y., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00986-2018 · Cited by 435
Self-citationDong, D., Tang, L., Li, Z. Y., Fang, M. J., Gao, J. B., Shan, X. H., Ying, X. J., Sun, Y. S., Fu, J., Wang, X. X., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz001 · Cited by 416
Self-citationDong, D., Fang, M.-J., Tang, L., Shan, X.-H., Gao, J.-B., Giganti, F., Wang, R.-P., Chen, X., Wang, X.-X., Palumbo, D., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.04.003 · Cited by 416
Self-citationDefining the biological basis of radiomic phenotypes in lung cancer
Grossmann, P., Stringfield, O., El-Hachem, N., Bui, M. M., Rios Velazquez, E., Parmar, C., Leijenaar, R. T., Haibe-Kains, B., Lambin, P., Gillies, R. J., et al. (2017) · eLife · doi:10.7554/elife.23421 · Cited by 365
Larue, R. T. H. M., Defraene, G., De Ruysscher, D., Lambin, P., & van Elmpt, W. (2017) · The British Journal of Radiology · doi:10.1259/bjr.20160665 · Cited by 363
Feng, L., Liu, Z., Li, C., Li, Z., Lou, X., Shao, L., Wang, Y., Huang, Y., Chen, H., Pang, X., et al. (2022) · The Lancet Digital Health · doi:10.1016/s2589-7500(21)00215-6 · Cited by 339
Self-citationPeng, H., Dong, D., Fang, M.-J., Li, L., Tang, L.-L., Chen, L., Li, W.-F., Mao, Y.-P., Fan, W., Liu, L.-Z., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3065 · Cited by 327
Self-citationIn-depth mining of clinical data: the construction of clinical prediction model with R
Zhou, Z.-R., Wang, W.-W., Li, Y., Jin, K.-R., Wang, X.-Y., Wang, Z.-W., Chen, Y.-S., Wang, S.-J., Hu, J., Zhang, H.-N., et al. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.08.63 · Cited by 301
Self-citationFeAture Explorer (FAE): A tool for developing and comparing radiomics models
Song, Y., Zhang, J., Zhang, Y.-D., Hou, Y., Yan, X., Wang, Y., Zhou, M., Yao, Y.-F., & Yang, G. (2020) · PLOS ONE · doi:10.1371/journal.pone.0237587 · Cited by 287
Park, J. E., Kim, D., Kim, H. S., Park, S. Y., Kim, J. Y., Cho, S. J., Shin, J. H., & Kim, J. H. (2020) · European Radiology · doi:10.1007/s00330-019-06360-z · Cited by 282
Sun, Q., Lin, X., Zhao, Y., Li, L., Yan, K., Liang, D., Sun, D., & Li, Z.-C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00053 · Cited by 263
Meyer, M., Ronald, J., Vernuccio, F., Nelson, R. C., Ramirez-Giraldo, J. C., Solomon, J., Patel, B. N., Samei, E., & Marin, D. (2019) · Radiology · doi:10.1148/radiol.2019190928 · Cited by 258
Kang, J., Choi, Y. J., Kim, I.-K., Lee, H. S., Kim, H., Baik, S. H., Kim, N. K., & Lee, K. Y. (2021) · Cancer Research and Treatment · doi:10.4143/crt.2020.974 · Cited by 257
Jiang, Y., Chen, C., Xie, J., Wang, W., Zha, X., Lv, W., Chen, H., Hu, Y., Li, T., Yu, J., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.007 · Cited by 184
Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer
Jiang, Y., Li, T., Liang, X., Hu, Y., Huang, L., Liao, Z., Zhao, L., Han, Z., Zhu, S., Wang, M., et al. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2017.1087 · Cited by 152
Aliko, V., Multisanti, C. R., Turani, B., & Faggio, C. (2022) · Sustainability · doi:10.3390/su141811784 · Cited by 110
Shao, L., Liu, Z., Feng, L., Lou, X., Li, Z., Zhang, X.-Y., Wan, X., Zhou, X., Sun, K., Zhang, D.-F., et al. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08659-4 · Cited by 92
Self-citationWang, Y., Zhao, Z.-J., Kang, X.-R., Bian, T., Shen, Z.-M., Jiang, Y., Sun, B., Hu, H.-B., & Chen, Y.-S. (2020) · Aging · doi:10.18632/aging.104095 · Cited by 85
Omics Technologies Improving Breast Cancer Research and Diagnostics
Orsini, A., Diquigiovanni, C., & Bonora, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612690 · Cited by 52
Ubink, I., Elias, S. G., Moelans, C. B., Laclé, M. M., van Grevenstein, W. M. U., van Diest, P. J., Borel Rinkes, I. H. M., & Kranenburg, O. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw303 · Cited by 40
Shi, R., Niu, Z., Wu, B., Zhang, T., Cai, D., Sun, H., Hu, Y., Mo, R., & Hu, F. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s244061 · Cited by 32
Feng, B., Chen, X., Chen, Y., Li, Z., Hao, Y., Zhang, C., Li, R., Liao, Y., Zhang, X., Huang, Y., et al. (2019) · Clinical Radiology · doi:10.1016/j.crad.2019.03.018 · Cited by 28
Self-citationPancreatic Adenocarcinoma: Imaging Modalities and the Role of Artificial Intelligence
Anghel, C., Mugur, G. C., Anghel, D. A., Rusu-Munteanu, G. I., Dumitru, R. L., & Lupescu, I. G. (2024) · doi:10.20944/preprints202401.0904.v1 · Cited by 23
Mao, R., & Li, J. (2024) · BMC Medical Genomics · doi:10.1186/s12920-024-02008-0 · Cited by 5
Metadata
- Authors
- Huang, Y.-Q., Liang, C.-H., He, L., Tian, J., Liang, C.-S., Chen, X., Ma, Z.-L., & Liu, Z.-Y.
- Venue
- Journal of Clinical Oncology
- Published
- 2016-06-20
- Volume
- 34
- Issue
- 18
- Pages
- 2157-2164
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2346343836
- Cited by
- 1,765
- References
- 40
- FWCI
- 88.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.